Computer-aided pattern scoring (C@PS): a novel cheminformatic workflow to predict ligands with rare modes-of-action

被引:3
作者
Stefan, Sven Marcel [1 ,2 ,3 ,4 ,5 ]
Stefan, Katja [1 ,2 ,3 ,4 ]
Namasivayam, Vigneshwaran [3 ,4 ,6 ]
机构
[1] Univ Oslo, Rikshospitalet, Dept Pathol, Sognsvannsveien 20, N-0372 Oslo, Norway
[2] Oslo Univ Hosp, Rikshospitalet, Sognsvannsveien 20, N-0372 Oslo, Norway
[3] Univ Lubeck, Lubeck Inst Expt Dermatol, Med Chem & Syst Polypharmacol, Med Syst Biol Div, Ratzeburger Allee 160, D-23538 Lubeck, Germany
[4] Univ Med Ctr Schleswig Holstein, Ratzeburger Allee 160, D-23538 Lubeck, Germany
[5] Med Univ Lublin, Dept Biopharm, Chodzki 4a, PL-20093 Lublin, Poland
[6] Univ Bonn, Pharmaceut Inst, Dept Pharmaceut & Cellbiol Chem, Immenburg 4, D-53121 Bonn, Germany
关键词
RESISTANCE-ASSOCIATED PROTEIN-1; COLLATERAL SENSITIVITY; TRANSPORT; DERIVATIVES; CELLS; INHIBITORS; VERAPAMIL; ANALOGS; EFFLUX; MRP1;
D O I
10.1186/s13321-024-00901-5
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The identification, establishment, and exploration of potential pharmacological drug targets are major steps of the drug development pipeline. Target validation requires diverse chemical tools that come with a spectrum of functionality, e.g., inhibitors, activators, and other modulators. Particularly tools with rare modes-of-action allow for a proper kinetic and functional characterization of the targets-of-interest (e.g., channels, enzymes, receptors, or transporters). Despite, functional innovation is a prime criterion for patentability and commercial exploitation, which may lead to therapeutic benefit. Unfortunately, data on new, and thus, undruggable or barely druggable targets are scarce and mostly available for mainstream modes-of-action only (e.g., inhibition). Here we present a novel cheminformatic workflow-computer-aided pattern scoring (C@PS)-which was specifically designed to project its prediction capabilities into an uncharted domain of applicability. The presented workflow tackles, for the first time, the challenge of data scarcity particularly focusing rare modes-of-action. In addition, the workflow and associated dataset provide new standards in the definition and application of criteria to rationalize drug candidate selection addressing important gaps in cheminformatics as well as computational and medicinal chemistry.
引用
收藏
页数:14
相关论文
共 36 条
[1]   Iodination of verapamil for a stronger induction of death, through GSH efflux, of cancer cells overexpressing MRP1 [J].
Barattin, Regis ;
Perrotton, Thomas ;
Trompier, Doriane ;
Lorendeau, Doriane ;
Di Pietro, Attilio ;
d'Hardemare, Amaury Du Moulinet ;
Baubichon-Cortay, Helene .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (17) :6265-6274
[2]   Advances in covalent drug discovery [J].
Boike, Lydia ;
Henning, Nathaniel J. ;
Nomura, Daniel K. .
NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (12) :881-898
[3]   The antiretroviral protease inhibitors indinavir and nelfinavir stimulate Mrp1-mediated GSH export from cultured brain astrocytes [J].
Brandmann, Maria ;
Tulpule, Ketki ;
Schmidt, Maike M. ;
Dringen, Ralf .
JOURNAL OF NEUROCHEMISTRY, 2012, 120 (01) :78-92
[4]   Detection and Assignment of Common Scaffolds in Project Databases of Lead Molecules [J].
Clark, Alex M. ;
Labute, Paul .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (02) :469-483
[5]  
Coleman Niamh, 2021, Am Soc Clin Oncol Educ Book, V41, P1, DOI [10.1200/edbk_325885, 10.1200/EDBK_325885]
[6]   Verapamil-stimulated glutathione transport by the multidrug resistance-associated protein (MRP1) in leukaemia cells [J].
Cullen, KV ;
Davey, RA ;
Davey, MW .
BIOCHEMICAL PHARMACOLOGY, 2001, 62 (04) :417-424
[7]   Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition [J].
Hanssen, Kimberley M. ;
Haber, Michelle ;
Fletcher, Jamie, I .
DRUG RESISTANCE UPDATES, 2021, 59
[8]   Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy-coupling factor transporters (ECFTs) [J].
Haupenthal, Joerg ;
Rafehi, Muhammad ;
Kany, Andreas M. ;
Lespine, Anne ;
Stefan, Katja ;
Hirsch, Anna K. H. ;
Stefan, Sven Marcel .
ARCHIV DER PHARMAZIE, 2024, 357 (09)
[9]   Global vision of druggability issues: applications and perspectives [J].
Hussein, Hiba Abi ;
Geneix, Colette ;
Petitjean, Michel ;
Borrel, Alexandre ;
Flatters, Delphine ;
Camproux, Anne-Claude .
DRUG DISCOVERY TODAY, 2017, 22 (02) :404-415
[10]   Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice [J].
Krohn, Markus ;
Lange, Cathleen ;
Hofrichter, Jacqueline ;
Scheffler, Katja ;
Stenzel, Jan ;
Steffen, Johannes ;
Schumacher, Toni ;
Bruening, Thomas ;
Plath, Anne-Sophie ;
Alfen, Franziska ;
Schmidt, Anke ;
Winter, Felix ;
Rateitschak, Katja ;
Wree, Andreas ;
Gsponer, Joerg ;
Walker, Lary C. ;
Pahnke, Jens .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (10) :3924-3931